Epidemiology, clinical features and evolution of Crohn's disease: A study of 60 cases;Epidemiologia, aspectos clinicos e evolutivos da doenca de Crohn: Um estudo de 60 casos

Arquivos de Gastroenterologia

Volumn 35, Issue 4, 1998, Pages 240-246

  Gaburri, Pedro Duarte ^a,b,f   Chebli, Júlio Maria Fonseca ^a,b   De Castro, Lincoln Eduardo Vieira Vilela ^a,b   Ferreira, José Olindo Duarte ^a,b   Lopes, Marcelo Henrique Marques ^a,b   Ribeiro, Alessandra Maria Barreto ^a   Alves, Rodrigo Andrade ^a,c   Froede, Edilson Cavalcante ^a,c   De Oliveira, Karla Suva ^a,c   Gaburri, Ana Karla ^a,d   Gaburri, Débora ^a,b   De Souza Portes Meirelles, Gustavo ^a,b   De Souza, E Aécio Flávio Meirelles ^a,e  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b Dept Gastroenterlogia da UFJF ^*

^c Medico Residente Serv G

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e HU UFJF

^f HU UFJF ^*  (Brazil)

Author keywords

Crohn disease; Epidemiology

Indexed keywords

AMINOSALICYLIC ACID; IMMUNOMODULATING AGENT; METRONIDAZOLE; PREDNISOLONE;

ARTICLE; CROHN DISEASE; DATA ANALYSIS; DOSE RESPONSE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PERITONITIS; RISK FACTOR; SYMPTOMATOLOGY; ADULT; BRAZIL; FEMALE; INCIDENCE; MALE; ONSET AGE; PATHOPHYSIOLOGY;

ADULT; AGE OF ONSET; BRAZIL; CROHN DISEASE; FEMALE; HUMANS; INCIDENCE; MALE;

EID: 0032177069     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Aranda R. Horgan K. Immunosupressive drugs in the treatment of inflammatory bowel disease. Semin Gastrointest Dis, 9:2, 1998.
2. Best WR, Becktel JM, Singleton JW, Kern Jr. F Development of a Crohn's disease active index. National Cooperative Crohn's Disease Study. Gastroenterology, 70:439, 1976.
3. Binder V, Hendricksen C, Kreiner S. Prognosis in Crohn's disease based on results from a regional patient group from the county of Copenhagen. Gut, 26:146, 1985.
4. Brynscov J, Freund J, Norby RS, Lauritsen K, Shaffalitzky de Muckadell O. Williams CN, McDonald AS, Tanton R, Molina F, Campanini MC. Final report on a placebo-controlled, double-blind, randomized, multicenter trial of cyclosporine treatment in active chronic Crohn's disease. Scand J Gastroenterol, 26:689, 1991.
5. Crohn BB. Ginzburg L, Oppenheimer GD. Regional ileitis. A pathologic and clinical entity. JAMA, 99:1323, 1932.
6. Deusch K. Obestadt K. Schaedel W, Classen M. P-Anca as a diagnostic marker in ulceralive colitis. Adv Exp Med Biol, 336:527, 1993.
7. Feagan BG. McDonald JWD, Rochon J, Laupacis A, Fedorack RN, Kinnear D. Saibil F. Groll A, Archambault A, Gillies R, Valberg B, Irvine EJ. Low-dose cyclosporine for the treatment of Crohn's disease. N Engl J Med, 330:1846, 1995.
8. Feagan BG. Rochon J. Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH. Grecnbcrg GR, Gillies R, Hopkins M, Hanauer SB, McDonald JWD. Methotrexate for the treatment of Crohn's disease. N Engl J Med, 332:292, 1995.
9. Greenstein AJ. Sachar DB, Smith H, Janowitz HD, Aufses Jr. AH. A comparison of risk in Crohn's disease and ulcerative colitis. Cancer, 48:2742, 1981.
10. Hanauer SB. Inflammatory bowel disease. N Engl J Med, 334:841, 1996.